miR-188-3p in colorectal cancer

Purpose: Characterization of colorectal cancer (CRC) transcriptome by high-throughput techniques has enabled the discovery of several differentially expressed involving previously unreported microRNAs abnormalities. Here, we followed a systematic approach on a global scale to identify microRNAs as clinical outcome predictors, and further validated them in the clinical and experimental setting. Experimental Design: Genome-wide microRNA sequencing data of 228 CRC patients from the cancer genome atlas (TCGA) dataset were analyzed as a screening cohort to identify microRNAs significantly associated with survival according to stringent pre-specified criteria. A panel of six microRNAs was further validated for their prognostic utility in a large independent validation cohort (n=332). In situ hybridization and functional experiments in a panel of CRC cell lines and xenografts further clarified the role of clinical relevant miRNAs. Results: Six microRNAs (miR-92b-3p, miR-188-3p, miR-221-5p, miR-331-3p, miR-425-3p and miR-497-5p) were identified as strong predictors of survival in the screening cohort. High miR-188-3p expression proves to be an independent prognostic factor (screening cohort: hazard ratio = 4.137, 95%CI=1.568-10.917, p=0.004; validation cohort: hazard ratio HR=1.538, 95%CI=1.107-2.137, p=0.010, respectively). Forced miR-188-3p expression increased migratory behavior of CRC cells in vitro and metastases formation in vivo (p<0.05). The pro-migratory role of miR-188-3p is mediated by direct interaction with MLLT4, a novel identified player involved in CRC cell migration. Conclusions: MiR-188-3p is a novel independent prognostic factor in CRC patients which can be partly explained by its effect on MLLT4 expression and migration of cancer cells.

from Cancer via ola Kala on Inoreader http://ift.tt/2c66XdI
via IFTTT